Login/Sign Up
Glibcla MP 5mg/500mg/15mg Tablet belongs to the group of medications called ‘antidiabetic agents’ used in the treatment of Type 2 diabetes mellitus. Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (metabolizes glucose), or if produced, it cannot function properly in the body.
Glibcla MP 5mg/500mg/15mg Tablet is a combination of three medicines, namely: Glibenclamide, Metformin, and Pioglitazone. Glibenclamide increases the production of insulin by acting on the pancreas. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Pioglitazone works by decreasing the amount of glucose released by the liver and improving the sensitivity of tissues of muscles and fats towards insulin effects.
You should take this medicine as prescribed by your doctor. You may experience side-effects of such as nausea (feeling sick), vomiting (falling sick), diarrhoea, stomach ache, respiratory infection, weight gain, numbness, and vision problems. Some patients experience decline in blood sugar levels lower than normal (hypoglycemia) resulting in sweating, dizziness, headache, confusion, feeling hungry, temporary changes in vision, uneasiness, irritability, and weakness. In such cases, seek medical attention immediately.
Do not take Glibcla MP 5mg/500mg/15mg Tablet if you are allergic to any of its contents. Before taking Glibcla MP 5mg/500mg/15mg Tablet, inform your doctor if you are taking other medicines that include prescription or non-prescription medicines, nutritional supplements, or herbal products. Do not stop this medication abruptly, even if you feel better. Glibcla MP 5mg/500mg/15mg Tablet may cause ‘lactic acidosis’ (accumulation of lactic acid in the blood), which requires immediate medical attention. The risk increases if you are previously diagnosed with kidney or liver diseases. Do not consume alcohol (risk of lactic acidosis) or fast for prolonged periods (risk of hypoglycemia). Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Glibcla MP 5mg/500mg/15mg Tablet contains three medicines, namely: Glibenclamide, Metformin, and Pioglitazone. Glibenclamide increases the production of insulin by acting on the pancreas. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Pioglitazone works by decreasing the amount of glucose released by the liver and improving the sensitivity of tissues of muscles and fats towards insulin effects. Together Glibcla MP 5mg/500mg/15mg Tablet decreases the elevated blood sugar level after the meal along with the recommended diet and exercise.
Glibcla MP 5mg/500mg/15mg Tablet may cause ‘lactic acidosis’ (buildup of lactic acid in the blood), characterized by abdominal pain, muscle cramps, vomiting, severe fatigue, and difficulty breathing. It is a life-threatening condition that requires immediate medical attention. Inform your doctor if you have any severe liver or kidney problems as their normal functioning is required to eliminate excess lactic acid from the body. Do not consume excess alcohol as it increases the risk of lactic acidosis. It should be used with caution in patients with heart diseases as it increases the risk of heart failure.
Drug-Drug Interactions: Do not take the antifungal drug (miconazole and fluconazole) or iodine contrast agents (used for X-ray or scan) while using Glibcla MP 5mg/500mg/15mg Tablet. Glibcla MP 5mg/500mg/15mg Tablet may interact with medications used to treat high blood pressure like (ritodrine, salbutamol, and bosentan), bile acid sequestrants (lower cholesterol levels), drugs used to treat skin inflammation such as corticosteroids, pain killer (phenylbutazone), a medication used to treat mental illness (chlorpromazine), a medication used to reduce urine production (desmopressin), a medication used to treat endometriosis (danazol), antidiabetics (gemfibrozil), and antibiotics (rifampicin).
Drug-Food Interactions: Taking Glibcla MP 5mg/500mg/15mg Tablet with alcoholic beverages may increase the risk of a rare but serious and potentially life-threatening condition known as lactic acidosis (build-up of lactic acid in the blood) and hypoglycemia.
Drug-Disease Interactions: Glibcla MP 5mg/500mg/15mg Tablet should be avoided in patients with congestive heart failure (heart-related issues), type I diabetes, liver diseases, kidney diseases, hormonal problems, and infectious illnesses, and edema.
Type 2 diabetes mellitus: Type 2 diabetes mellitus is a chronic condition in which blood glucose levels are elevated in the body. Insulin is responsible for the utilization of glucose by the cells. In type 2 diabetes, the body cells do not respond to insulin, or in later stages, your body may not produce enough insulin. Symptoms include excessive thirst, excessive hunger, fatigue, increased appetite, and dry mouth. This condition may worsen over time and cause toxic effects if not properly treated.
About Glibcla MP 5mg/500mg/15mg Tablet
Glibcla MP 5mg/500mg/15mg Tablet belongs to the group of medications called ‘antidiabetic agents’ used in the treatment of Type 2 diabetes mellitus. Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (metabolizes glucose), or if produced, it cannot function properly in the body.
Glibcla MP 5mg/500mg/15mg Tablet is a combination of three medicines, namely: Glibenclamide, Metformin, and Pioglitazone. Glibenclamide increases the production of insulin by acting on the pancreas. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Pioglitazone works by decreasing the amount of glucose released by the liver and improving the sensitivity of tissues of muscles and fats towards insulin effects.
You should take this medicine as prescribed by your doctor. You may experience side-effects of such as nausea (feeling sick), vomiting (falling sick), diarrhoea, stomach ache, respiratory infection, weight gain, numbness, and vision problems. Some patients experience decline in blood sugar levels lower than normal (hypoglycemia) resulting in sweating, dizziness, headache, confusion, feeling hungry, temporary changes in vision, uneasiness, irritability, and weakness. In such cases, seek medical attention immediately.
Do not take Glibcla MP 5mg/500mg/15mg Tablet if you are allergic to any of its contents. Before taking Glibcla MP 5mg/500mg/15mg Tablet, inform your doctor if you are taking other medicines that include prescription or non-prescription medicines, nutritional supplements, or herbal products. Do not stop this medication abruptly, even if you feel better. Glibcla MP 5mg/500mg/15mg Tablet may cause ‘lactic acidosis’ (accumulation of lactic acid in the blood), which requires immediate medical attention. The risk increases if you are previously diagnosed with kidney or liver diseases. Do not consume alcohol (risk of lactic acidosis) or fast for prolonged periods (risk of hypoglycemia). Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
₹76.5*
MRP ₹85
10% off
₹72.25*
MRP ₹85
15% CB
₹12.75 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Available Offers
Manufacturer/Marketer address
Glibcla MP 5mg/500mg/15mg Tablet is a combination of three antidiabetic medicines, Glibenclamide, Metformin, and Pioglitazone. It works by increasing the production of insulin, helping to restore your body's appropriate response to insulin, and thereby lowering your elevated blood sugar levels.
Glibcla MP 5mg/500mg/15mg Tablet is used to treat type 2 diabetes. It is not recommended for the treatment of type 1 diabetes.
Glibcla MP 5mg/500mg/15mg Tablet may cause hypoglycemia (low blood sugar levels). Hypoglycemia can occur if you miss or delay your food, drink alcohol, intense exercise, or take other antidiabetic medicine along with this medicine. So, take your medicine as advised by your doctor to avoid any unwanted effects of this medicine.
You may experience symptoms such as increased thirst and hunger, frequent urination, weight loss, delayed wound healing, and frequent infections if you have diabetes. Consult a doctor to confirm the diagnosis.
If you feel that your blood sugar levels are dropping, eat glucose tablets or chocolate immediately. This will help to increase your sugar levels instantly. So, it is always advised to carry glucose tablets or sugar candies with you.
Alcohol
Caution
Alcohol may increase the risk of side-effects and worsen the condition.
Pregnancy
Unsafe
Glibcla MP 5mg/500mg/15mg Tablet is a category C drug and may cause harmful effects to the unborn baby. So, it is used only when the benefits of this medicine outweigh the risks.
Breast Feeding
Unsafe
Glibcla MP 5mg/500mg/15mg Tablet should not be used in breastfeeding mothers as it may get secreted in the breast milk and cause unwanted effects in the nursing babies.
Driving
Caution
Glibcla MP 5mg/500mg/15mg Tablet may cause vision problems. So, do not drive or operate heavy machinery if you have any problems with your vision while using Glibcla MP 5mg/500mg/15mg Tablet.
Liver
Caution
Glibcla MP 5mg/500mg/15mg Tablet should be taken with caution especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor.
Kidney
Caution
Glibcla MP 5mg/500mg/15mg Tablet should be taken with caution in patients with kidney diseases. The dose may have to be adjusted by your doctor.
Children
Unsafe
Glibcla MP 5mg/500mg/15mg Tablet is not recommended for use in children below 18 years of age.
Product Substitutes
Uses of Glibcla MP 5mg/500mg/15mg Tablet
Medicinal Benefits
Glibcla MP 5mg/500mg/15mg Tablet contains three medicines, namely: Glibenclamide, Metformin, and Pioglitazone. Glibenclamide increases the production of insulin by acting on the pancreas. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Pioglitazone works by decreasing the amount of glucose released by the liver and improving the sensitivity of tissues of muscles and fats towards insulin effects. Together Glibcla MP 5mg/500mg/15mg Tablet decreases the elevated blood sugar level after the meal along with the recommended diet and exercise.
Side Effects of Glibcla MP 5mg/500mg/15mg Tablet
Directions for Use
Storage
Drug Warnings
Glibcla MP 5mg/500mg/15mg Tablet may cause ‘lactic acidosis’ (buildup of lactic acid in the blood), characterized by abdominal pain, muscle cramps, vomiting, severe fatigue, and difficulty breathing. It is a life-threatening condition that requires immediate medical attention. Inform your doctor if you have any severe liver or kidney problems as their normal functioning is required to eliminate excess lactic acid from the body. Do not consume excess alcohol as it increases the risk of lactic acidosis. It should be used with caution in patients with heart diseases as it increases the risk of heart failure.
Therapeutic Class
Drug-Drug Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Type 2 diabetes mellitus: Type 2 diabetes mellitus is a chronic condition in which blood glucose levels are elevated in the body. Insulin is responsible for the utilization of glucose by the cells. In type 2 diabetes, the body cells do not respond to insulin, or in later stages, your body may not produce enough insulin. Symptoms include excessive thirst, excessive hunger, fatigue, increased appetite, and dry mouth. This condition may worsen over time and cause toxic effects if not properly treated.
by Others
by Others
by Others
by AYUR
by Others